Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Schedule of Revenue Recognition (Details)

v3.20.1
Revenue Recognition - Schedule of Revenue Recognition (Details) - USD ($)
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Total revenues $ 3,115,593 $ 2,472,517
Product - Functional Neurosurgery    
Total revenues 1,684,937 1,604,645
Product - Biologics and Drug Delivery    
Total revenues 172,846 284,910
Products - Therapy    
Total revenues 57,500
Product - Capital Equipment    
Total revenues 188,101 274,399
Product - Product Revenue    
Total revenues 2,103,384 2,163,953
Services - Capital Equipment and Other    
Total revenues 156,495 211,202
Services - Biologics and Drug Delivery    
Total revenues 855,714 97,362
Services - Service Revenue    
Total revenues $ 1,012,209 $ 308,564